Background: Magnesium influences hepatic lipid deposition in vertebrates, but the underlying mechanism is unknown.
Introduction
Magnesium, the second most abundant cellular cation, acts as a specific activator for >300 different enzymes and plays a predominant role in numerous metabolic pathways, such as the metabolism of carbohydrates, proteins, and lipids (1) . In terrestrial animals, several researchers have noted that dietary magnesium reduced hepatic lipid deposition and played an important role in the regulation of lipid metabolism (2, 3) . Magnesium is also an essential mineral in fish. However, magnesium concentrations are low in fresh water. The uptake of magnesium from the rearing water is not sufficient to satisfy the requirements of freshwater fish, and dietary magnesium supplementation is necessary (4) . At present, dietary magnesium requirements have been reported in different fish species, and quantitative dietary magnesium requirements ranged from 300 to 1000 mg/kg (4) (5) (6) (7) (8) (9) . Several experiments have evaluated the effect of magnesium supplementation on lipid content, but the results have been inconsistent. For example, Liang et al. (5) reported that magnesium supplementation >473 mg/kg markedly elevated lipid accumulation in the liver, muscle, and whole body. Magnesium supplementation increases body lipid accumulation in the guppy (6) . However, for grass carp, Wang et al. (7) indicated that a dietary magnesium addition >300 mg/kg tended to reduce the whole-body lipid content. Whole-fish lipid concentrations in common carp were reduced in fish fed diets containing magnesium >600 mg/kg (8) .
Lipids play a key role in growth and development in animals, including fish. However, excess body lipid accumulation causes many adverse effects. In fish, excessive body fat deposition, especially in the liver, reduces the harvest yields and causes serious health problems, thus posing serious threats to the sustainable development of aquaculture (10) . In general, lipid homeostasis is maintained by the regulation of lipogenesis (FA synthesis) and lipolysis (FA b-oxidation), and many crucial enzymes, transcription factors, and signaling pathways are involved in these processes (11) . Enzymes related to lipid metabolism include the lipolytic enzymes [such as adipose triacylglyceride lipase (ATGL), 4 hormonesensitive lipase (HSL), and carnitine palmitoyltransferase 1 (CPT 1)] and the lipogenic enzymes [such as glucose 6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6PGD), isocitrate dehydrogenase (ICDH), malic enzyme (ME), acetylCoA carboxylase (ACC), and FA synthase (FAS)] (11). Several key transcriptional factors, such as sterol-regulator element-binding protein-1 (SREBP1), and PPAR a (PPARA) and PPAR g (PPARG), are involved in the regulation of lipid homeostasis via lipolysis and lipogenesis (12) (13) (14) . Among signaling pathways involved in modulation of lipid metabolism, Janus kinase-signal transducers and activators of transcription (JAK-STAT) and AMP-activated protein kinase (AMPK) signaling pathways are the fundamental regulators of lipid metabolism; they control lipid anabolism and catabolism (15, 16) . AMPK, a multisubunit enzyme, is recognized as a major regulator of lipid metabolism because of its regulatory roles in the activities and gene expression of enzymes (17) . JAK-STAT cascade is a ubiquitous intracellular signaling pathway that transmits signals from extracellular receptors to the nucleus (15) . Furthermore, our recent study indicated that the JAK2-STAT3 pathway exerts important regulatory actions on lipid metabolism in yellow catfish (18) .
Yellow catfish (Pelteobagrus fulvidraco), an omnivorous freshwater fish, is considered a good candidate for freshwater culture in China and other Asian countries because of its delicious meat and high market value (19) . However, under intensive farming, the yellow catfish frequently exhibits excessive hepatic fat accumulation and severe fatty liver syndrome, which have an adverse effect on its health and aquaculture. How to reduce excess hepatic lipid deposition is an urgent issue for fish nutritionists. The hypothesis of this study was that magnesium would reduce hepatic lipid deposition by inhibiting lipogenesis and increasing lipolysis. To that end, the present study was conducted to determine the effects and mechanism of dietary magnesium levels influencing growth performance and lipid metabolism in yellow catfish.
Methods
Two experiments were performed. Expt. 1 was carried out to determine the effect of dietary magnesium concentrations on growth performance and lipid metabolism in yellow catfish. Expt. 2 was performed to explore the signaling pathways of magnesium influencing lipid metabolism in primary hepatocytes from yellow catfish. The experimental protocol was approved by the Committee of Huazhong Agricultural University on the Ethics of Laboratory Animal and Cell Experiments. Table 1 ). The experimental diets were formulated by following the protocol of Tan et al. (20) . The dietary magnesium concentration was measured by using inductively coupled plasma-atomic emission spectrometry, and the contents were 0.14, 0.87, and 2.11 g Mg/kg for the low-, intermediate-, and high-magnesium diets, respectively.
Experimental procedures. The experimental procedures were similar to those described in our previous study (20) . Two hundred seventy fish (mean 6 SEM: 3.43 6 0.02 g; 3 mo old; mixed sex) were assigned to 9 fiberglass tanks, 30 fish/tank. Each diet was distributed randomly to triplicate tanks. The experiment continued for 8 wk.
At the termination of the feeding study, the survival, specific growth rate (SGR), and weight gain (WG) were determined. Hepatic magnesium and lipid content, enzymatic activities, and gene expression were analyzed. Hepatic histology [hematoxylin and eosin (H&E) staining] and histochemical (Oil Red O staining) observations were undertaken. The viscerosomatic index (VSI), visceral adipose index (VAI), hepatosomatic index (HSI), and condition factor (CF) were determined.
Expt. 2: in vitro study
Primary hepatocytes from yellow catfish were isolated by following the protocol of Zhuo et al. (21) . To determine the signaling pathways of magnesium influencing lipid metabolism, 3 independent experiments were performed. In Expt. 2A, primary hepatocytes received 1 of 4 treatments: control, MgSO 4 (2 mM), AG490 (10 mM), or MgSO 4 (2 mM) + AG490 (10 mM). In Expt. 2B, primary hepatocytes received 1 of 4 treatments: control, MgSO 4 (2 mM), GW6471 (5 mM), or MgSO 4 (2 mM) + GW6471 (5 mM). In Expt. 2C, primary hepatocytes received 1 of 4 treatments: control, MgSO 4 (2 mM), Compound C (2 mM), or MgSO 4 (2 mM) + Compound C (2 mM). The inhibitors were added 2 h before the addition of MgSO 4 . The measured magnesium concentration in the cell culture medium was 0.74 6 0.03 mM. The concentrations of MgSO 4 and the specific inhibitors were selected according to previous experiments and our pilot studies (18, (21) (22) (23) . The serum magnesium concentration in yellow catfish was 4.17 6 0.35 mM. Total magnesium concentration is of physiological relevance compared with that in yellow catfish. Sampling occurred after 48 h of treatment.
Sample analysis
Determination of crude lipid and magnesium concentrations. Lipid concentration of the liver was measured by ether extraction, and magnesium content was determined by inductively coupled plasmaatomic emission spectrometry (24) .
Histological and histochemical analyses. Histological and histochemical analysis for livers was conducted according to the methods described previously (24, 25) . The quantified area of lipid droplets in the Oil Red O observation and hepatic vacuoles in the H&E observation were evaluated by using Image J software as described previously (24, 25) .
TG content and cell viability determination. Cell viability was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay according to the method used in our previous assay (21) . Cellular TG content was analyzed by using the glycerol 3-phosphate oxidase p-aminophenol method.
Determination of lipogenic enzymatic activities. Lipogenic enzymatic activities in the liver were assayed spectrophotometrically as described in the study by Chen et al. (24) . Activities of 6PGD were assayed by following the protocol of Barroso et al. (26) , and ME activity was assayed according to Wise and Ball (27) . ICDH enzymatic activities were measured by following the methods of Bernt and Bergmeyer (28), and FAS assay was based on the study by Chakrabarty and Leveille (29) . Soluble protein content of the homogenates was determined according to the study by Bradford (30) by using BSA as a standard.
Real-time qPCR. Relative mRNA levels were assayed by the real-time qPCR method by following the protocol by Pfaffl (31) . The appropriate primers of each gene are listed in Supplemental Table 2 . A set of 10 housekeeping genes (18S rRNA, ribosomal protein l7, b-actin, hypoxanthineguanine phosphoribosyltransferase, tubulin alpha chain, b-2-microglobulin, TATA-box-binding protein, glyceraldehyde-3-phosphate dehydrogenase, translation elongation factor, and ubiquitin-conjugating enzyme) were selected in order to test their transcriptional stability. Relative expression of the genes was calculated according to the 2 2DDCt method and normalized to the geometric mean of the best combination of 2 genes as assayed by geNorm (32) .
Statistical analysis
Results are expressed as means 6 SEMs. Before statistical analysis, an arcsine transformation was used before processing percentage data. All data were assayed for normality of distribution by using the Kolmogorov-Smirnov test. The homogeneity of variances among the treatments was tested by using BarlettÕs test. One-factor ANOVA with DuncanÕs multiple range test as the post hoc test was used to analyze the data in the in vitro study (Expt. 1). Two-factor ANOVA was applied to assess the effects of inhibitors, magnesium, and their interaction in primary hepatocytes (Expt. 2). If 2-factor ANOVA revealed a significant P-interaction (P < 0.05), the differences between the individual groups were assessed with DuncanÕs multiple range test. The analysis was carried out with SPSS 19.0 software, and the minimum significance level was set at P < 0.05.
Results

Expt. 1: in vivo study
Growth performance and morphological parameters. In the feeding study, the survival was 100% among the 3 treatments ( Table 1) . SGR and WG increased 6.0-25% with increasing dietary magnesium supplementation (P < 0.05). The feed intakes for fish fed the high-magnesium diets (8.78 6 0.15 g/fish) were higher (2.0% and 8.6%, respectively) than those in the low-magnesium (8.25 6 0.08 g/fish) and intermediatemagnesium (8.09 6 0.12 g/fish) groups (P < 0.05). However, the feed conversion rate declined 6.6-12% with the increase of dietary magnesium supplementation (P < 0.05). CF, VAI, VSI, and HSI showed no significant differences between 3 groups.
H&E and Oil Red O staining. The amount of cytoplasmic vacuolation in the liver was reduced with increasing dietary magnesium concentrations ( Figure 1A-C) . The dietary magnesium addition reduced the amount of hepatic lipid droplets ( Figure 1D -F). These observations were further confirmed by the areas quantified for lipid droplets in the H&E-and Oil Red O-stained samples (Figure 2A, B) . H&E-and Oil Red O-relative areas in the liver of fish fed the intermediate-and high-magnesium diets were 43-54% lower than those in the low-magnesium group (P < 0.05). Lipid content and magnesium accumulation. The dietary magnesium addition reduced hepatic lipid content ( Figure 2C ). Hepatic lipid contents for fish fed the intermediate-(13.65% 6 0.52%) and high-magnesium (12.88% 6 0.69%) diets were 18% and 22% lower (P < 0.05) than those in the low-magnesium group (16.55% 6 0.44%), respectively. The hepatic magnesium content increased 18-34% with increasing dietary magnesium supplementation (P < 0.05) ( Figure 2D ).
Enzyme activities and gene expression involved in lipid metabolism. Hepatic G6PD activities showed no marked differences between the treatments ( Figure 3A) . Compared with the fish fed the low-magnesium diets, intermediate and high magnesium decreased (P < 0.05) 6PGD (3.7% and 3.8%) and ME (35% and 48%) lipogenic enzyme activities, respectively. The yellow catfish fed the intermediate-magnesium diets had (P < 0.05) lower hepatic ICDH (20% and 16%) and FAS (61% and 55%) activities than those in the low-and high-magnesium groups, respectively. The hepatic mRNA abundances of g6pd, 6pgd, fas, and acca for fish fed the intermediate-magnesium diets ( Figure 3B ) were lower (11-51%) than those in the low-and high-magnesium groups (P < 0.05). Relative mRNA concentrations of cpt 1, hsl, and accb showed no significant differences between the 3 groups. Compared with the fish fed the low-magnesium diets, intermediate and high magnesium increased mRNA concentrations of the lipolytic gene atgl (82% and 1.7-fold) and the transcriptional factor peroxisome proliferator-activated receptor (ppara) (18% and 1.0-fold), respectively. The relative mRNA abundance of pparg and srebp1 showed no significant differences between 3 groups. For the genes involved in the AMPK and JAK-STAT pathways ( Figure 3C ), the relative mRNA concentrations of ampka1, ampka2, ampkb1, ampkb2, ampkg1a, ampkg1b, jak2a, jak2b, and stat3 in fish fed a high-magnesium diet were (P < 0.05) higher (24% to 3.1-fold) than those in the low-and intermediate-magnesium groups. The ampkg2 mRNA concentrations presented no significant differences between the 3 groups.
Expt. 2: in vitro study TG concentration and cell viability. Cell viability showed no significant differences between the various treatments ( Figure 4A Figure 4B) . Compared with the control, incubation with AG490, GW6471, or Compound C individually showed no significant effects on TG concentration, but pretreatment with them followed by magnesium incubation (P < 0.05) alleviated the magnesium-evoked reduction in TG content (42%, 31%, or 56%, respectively).
The signaling pathways related to magnesium-influenced lipid deposition. In hepatocytes (Figure 5) , compared with the single magnesium treatment, AG490, GW6471, or Compound C pretreatment followed by magnesium incubation enhanced (13% to 1.5-fold, P < 0.05) the activities of G6PD and ME. The magnesium-induced reduction of ICDH and FAS activities was also alleviated (42-89%, P < 0.05) by AG490 and GW6471 incubation. Pretreatments with AG490 or Compound C followed by magnesium incubation alleviated the magnesium-induced downregulation of 6PGD activities (45% or 19%, respectively; P < 0.05).
AG490 and magnesium interacted to affect the mRNA concentrations of g6pd, 6pgd, acca, fas atgl, jak2a, jak2b, and stat3 (P-interaction <0.05) ( Figure 6A) . Compared with the control group, a single magnesium incubation downregulated (39-47%) the mRNA concentrations of g6pd, 6pgd, acca, and fas, but upregulated (39-48%) the mRNA concentrations of atgl, jak2a, jak2b, and stat3 (P < 0.05). The decreased mRNA concentrations of g6pd, 6pgd, acca, and fas and increased mRNA concentrations of atgl, jak2a, jak2b, and stat3 in the single-magnesium incubation group were abrogated in the AG490 + magnesium group (P < 0.05). GW6471 and magnesium interacted to affect the mRNA levels of g6pd, 6pgd, fas, atgl, and ppara (P-interaction <0.05) ( Figure 6B ). GW6471 pretreatment alleviated the magnesium-induced downregulation of g6pd, 6pgd, and fas mRNA concentrations (59%, 73% and 76%, respectively; P < 0.05) and reduced the upregulation of mRNA expression of atgl and ppara (48% and 85%, respectively; P < 0.05) ( Figure 6B ). Compound C and magnesium interacted to affect the mRNA concentrations of g6pd, 6pgd, acca, fas, atgl, ampka1, ampkb1, and amkg1a (P-interaction <0.05) ( Figure 7A, B) . Compared with the single magnesium FIGURE 3 Activity of enzymes (A) and expression of genes (B and C) involved in lipid metabolism in the liver of yellow catfish (Pelteobagrus fulvidraco) fed diets varying in magnesium concentration for 8 wk (Expt. 1). mRNA expression values were normalized to housekeeping genes expressed as a ratio of the lowmagnesium diet. Low magnesium = 0.14 g Mg/kg; intermediate magnesium = 0.87 g Mg/kg; high magnesium = 2.11 g Mg/kg. Values are means 6 SEMs [for analyzing lipogenic enzyme activities, n = 3 (replicates of 5 fish); for analyzing gene expression, n = 3 (replicates of 3 fish)]. Means for a gene without a common letter differ, P , 0.05 (onefactor ANOVA, DuncanÕs post hoc test). acc, acetyl-CoA carboxylase; AMPK, AMP-activated protein kinase; atgl, adipose triacylglyceride lipase; cpt 1, carnitine palmitoyltransferase 1; FAS, FA synthase; G6PD, glucose 6-phosphate dehydrogenase; hsl, hormone-sensitive lipase; ICDH, isocitrate dehydrogenase; JAK, janus kinase; ME, malic enzyme; ppar, peroxisome proliferator-activated receptor; srebp1, sterol-regulator element-binding protein-1; STAT, signal transducers and activators of transcription; 6PGD, 6-phosphogluconate dehydrogenase. treatment, Compound C pretreatment followed by the magnesium incubation enhanced (32% to 1.9-fold, P < 0.05) the mRNA concentrations of g6pd, 6pgd, acca, and fas, but downregulated (31-45%, P < 0.05) the mRNA levels of atgl, ampka1, ampkb1, and amkg1a.
Discussion
Several studies have investigated the effects of dietary magnesium concentrations on lipid deposition in fish; however, the results have been inconsistent. Furthermore, studies exploring the mechanisms underlying how dietary magnesium concentrations influenced lipid deposition are very scarce. In the present study, for the first time to our knowledge, we investigated the mechanism of the influence of a dietary magnesium addition on hepatic lipid deposition. Furthermore, using inhibitors of several signaling pathways, we explored the roles of PPARA, AMPK, and JAK2-STAT3 in the influence of magnesium on lipid deposition in fish. Our findings supported our starting hypothesis that a dietarymagnesium addition would alter intracellular signaling pathways, which would lead to changes in lipogenesis and lipolysis in fish.
FIGURE 5 Effects of JAK2-STAT3 inhibitor (A, AG490; 10 mmol/L), PPARA inhibitor (B, GW6471; 5 mmol/L), and AMPK inhibitor (C, Compound C; 2 mmol/L) on magnesium-induced variation of lipogenic enzyme activities in the primary hepatocytes from yellow catfish (Pelteobagrus Fulvidraco) (Expt. 2). After preincubation with the inhibitor for 2 h, the cells were incubated with 2 mmol MgSO 4 /L for 48 h in M199 medium. Values are means 6 SEMs, n = 3. Means for a gene without a common letter differ, P , 0.05 (2-factor ANOVA, DuncanÕs post hoc test). AMPK, AMP-activated protein kinase; FAS, fatty acid synthase; G6PD, glucose 6-phosphate dehydrogenase; ICDH, isocitrate dehydrogenase; JAK2-STAT3, Janus kinase 2-signal transducers and activators of transcription 3; ME, malic enzyme; NS, not significant (P . 0.05); 6PGD, 6-phosphogluconate dehydrogenase.
FIGURE 6
Effects of JAK2-STAT3 inhibitor (A, AG490; 10 mmol/L) and PPARA inhibitor (B, GW6471; 5 mmol/L) on magnesium-induced variation on the mRNA concentrations of genes involved in lipid metabolism in the primary hepatocytes of yellow catfish (Pelteobagrus fulvidraco) (Expt. 2). After preincubation with the inhibitor for 2 h, the cells were incubated with 2 mmol MgSO 4 /L for 48 h in M199 medium. mRNA expression values were normalized to housekeeping genes expressed as a ratio of the control. Values are means 6 SEMs, n = 3. Means for a gene without a common letter differ, P , 0.05 (2-factor ANOVA, DuncanÕs post hoc test). acc, acetyl-CoA carboxylase; atgl, adipose triacylglyceride lipase; cpt 1, carnitine palmitoyltransferase 1; fas, FA synthase; g6pd, glucose 6-phosphate dehydrogenase; hsl, hormonesensitive lipase; JAK, janus kinase; NS, not significant (P . 0.05); ppar, peroxisome proliferator-activated receptor; STAT, signal transducer and activator of transcription; 6pgd, 6-phosphogluconate dehydrogenase.
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During the trial period, the magnesium content present in the water was 4.02 mg/L. WG and SGR increased with increasing dietary magnesium concentrations. Like other fish (4) (5) (6) (7) (8) , yellow catfish fed magnesium-deficient diets showed poor growth performance and feeding efficiency. Moreover, the feed intake increased with increasing dietary magnesium concentrations. Yellow catfish fed a 2.11-g Mg/kg diet possessed markedly higher growth performance than those from the other 2 lowmagnesium groups, indicating that yellow catfish required higher dietary magnesium content to meet their requirement. Similarly, an improved growth rate was observed in common carp with the increase of dietary magnesium #3.2 g Mg/kg (8). Our study indicated that dietary magnesium concentrations showed no marked influences on morphological parameters (such as CF, HSI, VSI, and VAI). Similarly, Liang et al. (5) indicated that different concentrations of magnesium added to the basal diet showed no marked effects on intraperitoneal fat ratio, CF, HSI, or VSI in grass carp.
Dietary magnesium supplementation reduced the lipid content in the liver and hepatocytes. To investigate the mechanism for the variation of lipid accumulation as a response to dietary magnesium addition, the enzyme activities and the mRNA expression of genes related to lipid metabolism were analyzed. G6PD, 6PGD, ICDH, and ME play a predominant role in generating NAD(P)H, which is indispensable for lipogenesis (FA synthesis) (11) , and CPT I, HSL, and ATGL are considered critical enzymes responsible for catalyzing the hydrolysis of TGs (33) (34) (35) . A dietary-magnesium addition reduced hepatic 6PGD and ME activities, suggesting a suppression in lipogenic rate. atgl mRNA expression increased with the increase of dietary magnesium concentrations, indicating incremental lipolysis. Thus, our results indicated that the reduction of lipid content in the liver after magnesium treatment could be attributed to the upregulation of lipolysis and the downregulation of lipogenesis. PPARA is characterized as the key regulator of lipid metabolism by upregulating the mRNA concentrations of genes controlling FA mobilization and oxidation (12) . ppara mRNA concentrations increased with increasing dietary magnesium concentrations. The upregulation of ppara expression corresponded well with the enhancement of the mRNA abundances of the lipolytic gene atgl. Thus, it was possible that dietary magnesium might increase ppara expression and, consequently, upregulate atgl mRNA concentrations and stimulate lipolysis, which in turn reduces lipid deposition. For the genes involved in the AMPK and JAK-STAT pathways, the present study indicated that a highmagnesium diet upregulated the mRNA concentrations of ampka1, ampka2, ampkb1, ampkb2, ampkg1a, ampkg1b, jak2a, jak2b, and stat3. To the best of our knowledge, this is the first report focused on the changes of mRNA concentrations of these genes in fish fed different nutritional regimens, indicating that the dietary magnesium addition influenced the changes of their corresponding signaling pathways.
Our in vivo study indicated that magnesium influenced the mRNA concentrations of genes involved in signaling pathways (PPARA, AMPK, and JAK2-STAT3). In an attempt to elucidate the mechanisms that underlie lipid metabolism, we further explored the roles of these signaling pathways in magnesium influencing lipid metabolism in yellow catfish. The significant interaction effects between magnesium and specific signaling pathway inhibitors (AG490, GW6471, and Compound C) were first observed on lipid deposition and metabolism in hepatocytes. PPARA, JAK-STAT, and AMPK signaling pathways are the fundamental regulators of lipid metabolism via lipolysis and lipogenesis (12, 15, 16) . These results suggested that the pathways played an important role in the regulation of magnesium-induced changes in lipid deposition and metabolism of yellow catfish. AG490 pretreatment markedly enhanced the activities of G6PD, 6PGD, ICDH, ME, and FAS and the mRNA concentrations of 6pgd, g6pd, fas, and acca and downregulated the mRNA expression of atgl, jak2a, jak2b, and stat3. As a consequence, the reduction of hepatocyte TG accumulation was also partly reversed by the presence of AG490. These observations indicated that the JAK2-STAT3 pathways mediated the magnesium-induced changes in lipid deposition and metabolism. Similarly, studies suggested that a STAT3 inhibitor decreased ATGL mRNA expression and lipolysis in adipocytes (36) . Other studies also pointed out that the FAS and ACC mRNA concentrations were repressed by enhanced STAT3 expression in in vitro hepatocyte experiments (37) . Thus, the downregulation of expression of JAK2-STAT3 members may FIGURE 7 Relative mRNA levels of genes involved in lipid metabolism (A), and AMPK signaling pathways (B) in the primary hepatocytes of yellow catfish (Pelteobagrus fulvidraco) after a control or a single MgSO 4 incubation without or with Compound C. After preincubation with Compound C (2 mM) for 2 h, the cells were incubated with 2 mmol MgSO 4 /L for 48 h in M199 medium. mRNA expression values were normalized to housekeeping genes expressed as a ratio of the control. Values are means 6 SEMs, n = 3. Means for a gene without a common letter differ, P , 0.05 (2-factor ANOVA, DuncanÕs post hoc test). acc, acetyl-CoA carboxylase; AMPK, AMP-activated protein kinase; atgl, adipose triacylglyceride lipase; cpt 1, carnitine palmitoyltransferase 1; fas, fatty acid synthase; g6pd, glucose 6-phosphate dehydrogenase; hsl, hormone-sensitive lipase; NS, not significant (P . 0.05); 6pgd, 6-phosphogluconate dehydrogenase.
constitute a link between magnesium and enzymatic gene expression in yellow catfish.
The present study also indicated that GW6471 pretreatment significantly alleviated the magnesium-induced downregulation of the activities and mRNA concentrations of g6pd and fas and reduced the upregulation of mRNA expression of atgl and ppara. Considering that PPARA is a key modulator that could regulate the expression of lipolytic genes by binding to the corresponding response elements (12, 33) , it was plausible to speculate that magnesium reduced the hepatic lipid content by the PPARA pathway.
Having obtained convincing evidence that magnesium could influence the mRNA concentrations of several AMPK subunits, we next investigated whether the AMPK pathway was involved in the magnesium-induced changes of lipid metabolism. Here, Compound C pretreatment significantly alleviated magnesiuminduced downregulation of the mRNA concentrations of g6pd, 6pgd, acca, and fas and reduced the magnesium-induced increase of mRNA expression of atgl, ampka1, ampkb1, and ampkg1a. Compound C pretreatment also significantly enhanced the activities of G6PD, 6PGD, and ME. Enhanced lipogenesis and reduced lipolysis helps explain the increased hepatic lipid content after AMPK pathway inhibition by Compound C. In the liver, activated AMPK not only inhibits FA synthesis but also activates FA oxidation (16, 17) . Activated AMPK inhibits ACC activity and decreases FAS expression (38, 39) . AMPK stimulates lipolysis via phosphorylation of HSL and ATGL (16, 40) . Thus, it would be reasonable to conclude that the AMPK signaling pathways mediated the magnesium-evoked alterations of lipid metabolism.
In conclusion, in the present study, magnesium reduced hepatic lipid accumulation via modulation of enzymatic activities and gene transcriptional expression related to lipid metabolism. The PPARA, JAK-STAT, and AMPK signaling pathways mediated the magnesium-induced changes in lipogenesis and lipolysis. These results might help researchers better understand the complex regulatory mechanism in lipid metabolism and provide new insight for magnesium nutrition in vertebrates.
